Published in Healthcare Mergers, Acquisitions and Ventures Week, September 26th, 2009
"The expanded commercialization of Cylex's technology presents an exciting opportunity for the company to develop cellular diagnostics for diseases and treatments where...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.